Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDL.L Regulatory News (SDL)

  • There is currently no data for SDL

Trading Statement

15 Dec 2017 07:00

RNS Number : 4369Z
SDL PLC
15 December 2017
 

SDL plc

Trading Update

 

15 December 2017, Maidenhead, U.K. - SDL plc ("SDL" or "the Group"), a leader in global content management and language translation software and services, is providing an update on the trading performance for year ending 31 December 2017.

 

SDL's sales pipeline for the period is in line with expectations. However, the Group is reliant on the closure of certain software deals, which may not be processed and fully awarded by 31 December 2017. If these deals are not closed, Adjusted EBITA1 for 2017 on a like-for-like2 basis will be below current market expectations. The Group has also experienced a faster than forecast shift from perpetual licence sales to Software-as-a-Service (SaaS) sales. This has resulted in higher costs recognised in the year, with revenues deferred into future years.

 

In Language Services, SDL is pleased to report continued revenue growth and a recovery in gross margins, as expected. The Group has fully addressed the margin pressure and the two challenging contracts in Asia reported in the first half results. Our Language Services automation programme, 'Helix', is on track and set to deliver further gross margin gains during 2018. 

 

Our Language Technologies division has delivered good licence wins. In October, the Group also announced a number of upcoming product launches in the segments of content management ('Tridion DX') and AI-assisted content creation, to positive market response.

 

Improved processes and greater automation, introduced as part of SDL's transformation, will enable the Group to rationalise parts of its global operating and organisational model during 2018. As a result, SDL has taken action to reduce parts of its cost base. The Group expects to recognise an exceptional charge in 2017 of approximately £3.5 million and a slightly lower charge in 2018, as we look to complete the optimisation of our operating model.

 

However, to capitalise on the growth opportunities in the market, the Group plans to increase investment overall, with a focus on developing our premium solutions in fast-growing verticals, such as Life Sciences and Marketing Solutions, and to accelerate the development of our cloud-based, AI-powered Content Globalisation platform. Some of the core features of this platform, such as Machine Learning, will be, we believe, disruptive and industry leading.

 

The nature of our technology investments, coupled with improvements to the Group's systems and processes now require us to capitalise a small portion of our annual development spend, which has risen in the year. In 2017, the Group expects R&D capitalisation to be £2 million to £3 million, amortised over 3-4 years. For clarity, the positive benefit of this capitalisation is excluded from our commentary on the like-for-like Adjusted EBITA above.

 

The outlook for our industry remains very positive and, with the right level of investment, the Group believes it can move to the forefront of its industry. SDL remains committed to delivering double digit revenue growth and mid to high teens profit margins over the medium to long term.

 

1 Adjusted EBITA = Earnings Before Interest, Tax and Amortisation of Acquired Intangibles and Exceptional Items

2 Like-for-like basis = capitalised R&D in the period treated as an expense

 

For further information please contact:

 

SDL plc

01628 410100

Adolfo Hernandez, CEO

Xenia Walters, Interim CFO

FTI Consulting LLP

0203 727 1000

Dwight Burden / Emma Hall

 

About SDL

SDL (LSE:SDL) is the global innovator in language translation technology, services and content management. Over the past 25 years we've helped companies deliver transformative business results by enabling powerful, nuanced digital experiences with customers around the world. Are you in the know? Find out why 78 out of the top 100 global brands work with us at SDL.com and follow us on Twitter, LinkedIn and Facebook.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLFFVFFDLSLID
Date   Source Headline
9th Sep 20133:16 pmRNSHolding(s) in Company
6th Sep 20139:48 amRNSHolding(s) in Company
3rd Sep 20136:01 pmRNSHolding(s) in Company
28th Aug 20134:15 pmRNSTotal Voting Rights
27th Aug 20139:23 amRNSHolding(s) in Company
15th Aug 201310:20 amRNSHolding(s) in Company
12th Aug 20133:20 pmRNSApplication for Listing
6th Aug 20137:00 amRNSHalf Yearly Report
1st Aug 20133:18 pmRNSHolding(s) in Company
30th Jul 201312:00 pmRNSAnalyst and Investor Teach-in
29th Jul 20136:30 pmRNSHolding(s) in Company
12th Jul 20133:00 pmRNSNotice of Results
11th Jul 20136:04 pmRNSHolding(s) in Company
5th Jul 20135:53 pmRNSBlocklisting Interim Review
21st Jun 20139:54 amRNSHolding(s) in Company
21st Jun 20139:51 amRNSHolding(s) in Company
19th Jun 20135:51 pmRNSHolding(s) in Company
18th Jun 20137:00 amRNSTrading Update
5th Jun 20137:00 amRNSAppointment of Non-executive Chairman
30th May 20135:05 pmRNSTotal Voting Rights
30th Apr 20133:51 pmRNSAGM Statement
25th Apr 20137:00 amRNSInterim Management Statement
23rd Apr 201311:57 amRNSDirector/PDMR Shareholding
23rd Apr 20137:00 amRNSSDL Appoints Grant Johnson as CMO
18th Apr 20135:43 pmRNSHolding(s) in Company
9th Apr 20138:31 amRNSHolding(s) in Company
15th Mar 20139:24 amRNSHolding(s) in Company
15th Mar 20139:23 amRNSHolding(s) in Company
13th Mar 20135:11 pmRNSHolding(s) in Company
12th Mar 20132:29 pmRNSHolding(s) in Company
12th Mar 20137:00 amRNSFinal Results
6th Mar 20137:00 amRNSAcquisition of bemoko
5th Mar 20138:43 amRNSHolding(s) in Company
28th Feb 20136:03 pmRNSTotal Voting Rights
17th Jan 20137:00 amRNSTrading Update
28th Dec 201212:23 pmRNSBlocklisting Interim Review
28th Dec 201212:19 pmRNSTotal Voting Rights
20th Dec 201211:41 amRNSHolding(s) in Company
18th Dec 20123:58 pmRNSHolding(s) in Company
11th Dec 20123:39 pmRNSHolding(s) in Company
7th Dec 20124:58 pmRNSHolding(s) in Company
7th Dec 20124:54 pmRNSTotal Voting Rights
5th Dec 20128:42 amRNSDirector/PDMR Shareholding
4th Dec 20129:56 amRNSDirector/PDMR Shareholding
28th Nov 201210:18 amRNSHolding(s) in Company
28th Nov 201210:15 amRNSDirector/PDMR Shareholding
27th Nov 20122:19 pmRNSDirector/PDMR Shareholding
26th Nov 20127:00 amRNSTrading Update
12th Nov 20123:43 pmRNSHolding(s) in Company
5th Nov 20127:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.